/
/
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
1,594 Views
•
09:34 min
•
August 16, 2021
DOI:
1Department of Clinical Medicine, Trinity Translational Medicine Institute, St. James’s Hospital, Trinity College Dublin,The University of Dublin, 2School of Pharmacy and Biomolecular Sciences,Royal College of Surgeons in Ireland (RCSI), 3SFI Advanced Materials and Bioengineering Research (AMBER) Centre,RCSI & TCD, 4SFI Centre for Research in Medical Devices (CURAM), RCSI,Dublin and National University of Ireland
Summary
Automatically generated
Rapid and efficient quantification of intracellular M. tuberculosis growth is crucial for pursuing improved therapies against tuberculosis (TB). This protocol describes a broth-based colorimetric detection assay using an automated liquid culture system to quantify Mtb growth in macrophages treated with candidate host-directed therapies.
Explore More Videos
Automated Culture SystemHost-directed TherapiesTuberculosisMycobacterium TuberculosisIntracellular GrowthFDA-approved DrugsRepurposingMycobacterial CultureEO Carrier T-cell CultureAttenuated Mycobacterial CultureH37RaCentrifugationRPMIResuspensionMycobacterial SuspensionGlass Chamber SlidesPhagocytosisPBSPFA
Read Article
Cite this Article
O’Leary, S., Bahlool, A. Z., O’Connor, G., Cryan, S., Keane, J. M., O’Sullivan, M. P. An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis. J. Vis. Exp. (174), e62838, doi:10.3791/62838 (2021).
Copy